Significant: Hypoglycaemia. Blood and lymphatic system disorders: Rarely, anaemia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, haemolytic anaemia, erythrocytopenia.
Endocrine disorders: Hyperglycaemia. Eye disorders: Rarely, visual disturbances.
Gastrointestinal disorders: Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea, constipation, gastrointestinal haemorrhage.
General disorders and administration site conditions: Weakness. Hepatobiliary disorders: Rarely, cholestasis, jaundice, hepatitis. Infections and infestations: Viral infection. Investigations: Rarely, elevated hepatic enzyme levels, increased serum creatinine and BUN.
Musculoskeletal and connective tissue disorders: Arthralgia, arthritis, back pain. Nervous system disorders: Headache, dizziness, signs of adrenergic counter-regulation including hyperhidrosis, clammy skin, anxiety, tachycardia, palpitations, angina pectoris, cardiac arrhythmia and hypertension.
Renal and urinary disorders: UTI.
Respiratory, thoracic and mediastinal disorders: Bronchitis, rhinitis, pharyngitis, upper respiratory tract infection, cough.
Skin and subcutaneous tissue disorders: Rarely, rash, pruritus, urticaria, angioedema, erythema, maculopapular rashes, bullous reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms.